Total Visits

Views
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients28

Total Visits Per Month

February 2020March 2020April 2020May 2020June 2020July 2020August 2020
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients0101410

File Visits

Views
Stokke2018_Article_Pre-dosingWithLilotomabPriorTo.pdf9
4

Top country views

Views
Norway8
United States7
France4
China2
Germany2
Sweden2
Japan1
Netherlands1
Taiwan1

Top cities views

Views
Oslo8
Yulee5
Amsterdam1
Guangzhou1
Hangzhou1
Mountain View1
San Mateo1
Taipei1
Tokyo1